TRVI
NASDAQ · Pharmaceuticals
Trevi Therapeutics Inc
$14.33
+1.52 (+11.87%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+53.0% upside
Low Target
$18.04
Average Target
$21.93
High Target
$33.12
Current Price
$14.33
Current
$14.33
$14.33
Target
$21.93
$21.93
$18.04
$21.93 avg
$33.12
Scenario Analysis
Bear Case
$18.04
25.9%
Low target
Base Case
$21.93
+53.0%
Avg target
Bull Case
$33.12
+131.1%
High target
Risk/Reward
5.1x
Highly favorable
Price in Context
52-Week High
$20.22
-29.1% from high
52-Week Low
$9.82
+45.9% from low
Target vs 52W High
$21.93
+8.5% vs high
Next Earnings Report
Nov 11, 2026
2d
until earnings
EPS Est: $-0.14
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals